ELECTROPHYSIOLOGY — % Change
Johnson & Johnson ELECTROPHYSIOLOGY — % Change remained flat by 0.0% to 1.8% in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 43.1%, from 3.1% to 1.8%. Over 3 years (FY 2022 to FY 2025), ELECTROPHYSIOLOGY — % Change shows a downward trend with a -7.0% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
A positive percentage indicates accelerating sales growth, whereas a negative percentage suggests a contraction in market share or reduced demand for the product line.
Detailed definition
This metric measures the period-over-period percentage growth or decline in net sales for the electrophysiology product...
Peer comparison
Comparable to segment-level revenue growth rates reported by diversified healthcare and medical device companies.
jnj_segment_electrophysiology_changeHistorical Data
| FY'22 | FY'23 | FY'24 | FY'25 | |
|---|---|---|---|---|
| Value | 8.7% | 19.1% | 12.3% | 7% |
| YoY Change | — | +119.5% | -35.6% | -43.1% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Johnson & Johnson's electrophysiology — % change?
- Johnson & Johnson (JNJ) reported electrophysiology — % change of 1.8% in Q4 2025.
- How has Johnson & Johnson's electrophysiology — % change changed year-over-year?
- Johnson & Johnson's electrophysiology — % change decreased by 43.1% year-over-year, from 3.1% to 1.8%.
- What is the long-term trend for Johnson & Johnson's electrophysiology — % change?
- Over 3 years (2022 to 2025), Johnson & Johnson's electrophysiology — % change has grown at a -7.0% compound annual growth rate (CAGR), from 8.7% to 7.0%.
- What does electrophysiology — % change mean?
- The percentage change in revenue from electrophysiology products compared to a previous period.